Growth Metrics

Lipocine (LPCN) Interest Expenses (2018 - 2022)

Lipocine (LPCN) has disclosed Interest Expenses for 5 consecutive years, with $7568.0 as the latest value for Q2 2022.

  • For the quarter ending Q2 2022, Interest Expenses fell 86.82% year-over-year to $7568.0, compared with a TTM value of $7568.0 through Mar 2023, down 95.08%, and an annual FY2022 reading of $27098.0, down 86.67% over the prior year.
  • Interest Expenses was $7568.0 for Q2 2022 at Lipocine, down from $19529.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $223789.0 in Q1 2019 and bottomed at $7568.0 in Q2 2022.
  • Average Interest Expenses over 5 years is $118017.0, with a median of $87847.0 recorded in 2020.
  • The sharpest move saw Interest Expenses rose 16.27% in 2019, then plummeted 86.82% in 2022.
  • Year by year, Interest Expenses stood at $218577.0 in 2018, then decreased by 29.14% to $154881.0 in 2019, then plummeted by 47.62% to $81133.0 in 2020, then plummeted by 60.5% to $32051.0 in 2021, then crashed by 76.39% to $7568.0 in 2022.
  • Business Quant data shows Interest Expenses for LPCN at $7568.0 in Q2 2022, $19529.0 in Q1 2022, and $32051.0 in Q4 2021.